chartexchange

ANNX
Annexon, Inc. Common Stock
stockNASDAQ

At CloseNov 13, 2026 3:59:59 PM EST
3.93USD-1.008%(-0.04)2,585,707
Pre-marketNov 13, 2026 9:28:30 AM EST
3.99USD+0.504%(+0.02)
After-hoursNov 13, 2026 4:00:30 PM EST
3.92USD-0.254%(-0.01)
Loading…
Loading…
747.79M
Healthcare
Biotechnology
HQ
Brisbane, CA, USA
Previous Close
$3.97
Beta
1.44
52-Week High
$7.18 2026-01-23
52-Week Low
$2.54 2025-11-13
SMA 50
$4.04
SMA 200
$5.11
Avg. Vol 10D
3.58M
Avg. Vol 30D
3.61M
Avg. Vol 90D
3.27M
Relative Vol
0.72
190.76M
175.57M
28,984,850
0.4100%
3,500,000
449
Mar 29, 2027 (134d)
ANNX Profile

our mission is to develop disease-modifying therapeutics for patients suffering from neurological disorders such as huntington's disease and alzheimer's disease by targeting complement-mediated neurodegeneration (cmnd).

ANNX Performance
PeriodPriceDateChangeBeta
1W4.202026-11-06-6.67%1.325
1M3.832026-10-13+2.35%1.719
3M5.262026-08-13-25.48%1.490
6M5.452026-05-13-28.07%1.211
1Y2.682025-11-13+46.27%1.439
2Y6.552024-11-13-40.15%—
5Y16.452021-11-12-76.17%1.150
ANNX Stock Summary

Annexon, Inc. Common Stock (NASDAQ:ANNX) stock price today is $3.92, and today's volume is 2,585,707. ANNX is down 1.259% today. The 30 day average volume is 3.61M. ANNX market cap is $747.79M with 190.76M shares outstanding.